Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy.

Samir KhandhadiaSuresh ThulasidharanNguyen Thuy Vy HoangSameh Alkhalili IbrahimYanling OuyangAndrew John Lotery

Published in: Eye (London, England) (2022)

We found overall a mean improvement in VA and structural outcomes after PDT. In the absence of randomised clinical trials this study supports the use of half dose PDT for treatment of chronic CSCR.

Keyphrases

photodynamic therapy
clinical trial
fluorescence imaging
open label
double blind
study protocol
type diabetes
drug induced
placebo controlled
phase iii
weight loss